2 completed, 1 recruiting. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Recruiting 1 |
Follow Proliferative Diabetic Retinopathy - High Risk: new trials by email Literature Review of Proliferative Diabetic Retinopathy - High Risk trials Research Report on Proliferative Diabetic Retinopathy - High Risk
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy Bevacizumab - Proliferative Diabetic Retinopathy - High Risk | Not applicable | Recruiting | Christian Ophthalmic Surgery Expedition Network | 150 | 2025-03-20 | 2025-03-28 |
| Ultra-Widefield Fluorescein Angiography-Based Targeted Retinal Photocoagulation Versus Conventional Panretinal Photocoagulation in the Preservation of Visual Function and Regression of Proliferative Diabetic Retinopathy Green laser - Proliferative Diabetic Retinopathy - High Risk | Not applicable | Completed | Hayatabad Medical Complex | 120 | 2022-09-01 | 2024-10-23 |
| Patient Comfort Using Green vs. Yellow Pan Retinal Photocoagulation laser indirect ophthalmoscopy pan retinal photocoagulation - Proliferative Diabetic Retinopathy - High Risk | Not applicable | Completed | Wills Eye | 40 | 2016-03-01 | 2016-12-16 |
Diabetic Retinopathy (1) · Vitreous Hemorrhage (1)
Eye Diseases (2) · Cardiovascular Diseases (1) · Diabetes Complications (1) · Diabetes Mellitus (1) · Diabetic Angiopathies (1) · Endocrine System Diseases (1) · Eye Hemorrhage (1) · Hemorrhage (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Retinal Diseases (1) · Vascular Diseases (1)
Bevacizumab (1)
Christian Ophthalmic Surgery Expedition Network (1) · Hayatabad Medical Complex (1) · Wills Eye (1)
Mexico (1) · Pakistan (1) · United States (1)
Allen Chiang, MD (1) · Isaac Aleman, MD (1)